Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression

Neuropsychopharmacology

Volumn 29, Issue 11, 2004, Pages 2088-2096

  Si, Xiaohong ^a   Miguel Hidalgo, Jose Javier ^a   O'Dwyer, Gillian ^a   Stockmeier, Craig A ^a   Rajkowska, Grazyna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Astrocytes; Depression; Frontal lobe; Glia; Western blotting

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ATENOLOL; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; FLUOXETINE; GLIAL FIBRILLARY ACIDIC PROTEIN; LITHIUM; LORAZEPAM; METHYLPHENIDATE; NORTRIPTYLINE; PAROXETINE; RISPERIDONE; SERTRALINE; TEMAZEPAM; TIOTIXENE; TRAZODONE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; ASTROCYTE; BRAIN TISSUE; CADAVER; CALCULATION; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIA CELL; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; ONSET AGE; OPTICAL DENSITY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; TIME OF DEATH; WESTERN BLOTTING;

EID: 8444245234     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300525     Document Type: Article

References (24)

1. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE (1996). Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol (Berl) 91: 269-277.
2. Comings DE (1982). Two-dimensional gel electrophoresis of human brain proteins. III. Genetic and non-genetic variations in 145 brains. Clin Chem 28: 798-804.
3. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP (2002a). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12: 386-394.
4. Cotter D, Mackay D, Landau S, Kerwin R, Everall I (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58: 545-553.
5. Cotter D, Pariante C, Rajkowska G (2002b). Glial pathology in major psychiatric disorders. In Agam G, Belmaker RH, Everall I (eds). The Post-Mortem Brain in Psychiatric Research. Kluwer Academic Publishers: Boston, pp 291-324.
6. Damadzic R, Bigelow LB, Krimer LS, Goldenson DA, Saunders RC, Kleinman JE et al (2001). A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis. Brain Res Bull 55: 611-618.
7. David JP, Ghozali F, Fallet-Bianco C, Wattez A, Delaine S, Boniface B et al (1997). Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci Lett 235: 53-56.
8. Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT (2002). Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study. J Neurol Neurosurg Psychiatry 73: 556-560.
9. Heun R, Kockler M, Papassotiropoulos A (2000). Distinction of early- and late-onset depression in the elderly by their lifetime symptomatology. Int J Geriatr Psychiatry 15: 1138-1142.
10. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF et al (2000). Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5: 142-149.
11. Kimura T, Budka H (1986). Glial fibrillary acidic protein and S-100 protein in human hepatic encephalopathy: immunocytochemical demonstration of dissociation of two glia-associated proteins. Acta Neuropathol (Berl) 70: 17-21.
12. Knable MB, Torrey EF, Webster MJ, Bartko JJ (2001). Multivariate analysis of prefrontal cortical data from the Stanley foundation neuropathology consortium. Brain Res Bull 55: 651-659.
13. Kril JJ, Flowers D, Butterworth RF (1997). Distinctive pattern of Bergmann glial pathology in human hepatic encephalopathy. Mol Chem Neuropathol 31: 279-287.
14. Krishnan KR, Hays JC, Tupler LA, George LK, Blazer DG (1995). Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry 152: 785-788.
15. Lavretsky H, Lesser IM, Wohl M, Miller BL (1998). Relationship of age, age at onset, and sex to depression in older adults. Am J Geriatr Psychiatry 6: 248-256.
16. Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA et al (2000). Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 48: 861-873.
17. Nichols NR, Day JR, Laping NJ, Johnson SA, Finch CE (1993). GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14: 421-429.
18. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95: 13290-13295.
19. Rajkowska G (2003). Depression: what we can learn from postmortem studies. Neuroscientist 9: 273-284.
20. Rajkowska G, Goldman-Rakic PS (1995). Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria. Cereb Cortex 5: 307-322.
21. Rajkowska G, Halaris A, Selemon LD (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49: 741-752.
22. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45: 1085-1098.
23. Stoltenburg-Didinger G, Punder I, Peters B, Marcinkowski M, Herbst H, Winneke G et al (1996). Glial fibrillary acidic protein and RNA expression in adult rat hippocampus following low-level lead exposure during development. Histochem Cell Biol 105: 431-442.
24. Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH (2001). Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 15: 388-400.